endpts.com·May 28, 2026
Biopharma sentiment has reached its highest level since a downturn, as Frank Fan, the former founding scientist at Legend Biotech, prepares to showcase his new project after relocating to Shenzhen, China in 2022.
The article highlights that biopharma sentiment has reached its highest point since a downturn, which suggests a positive market outlook and potential investment opportunities in the sector. For someone tracking biotech IPOs and emerging health startups, this could signal a ripe environment for new ventures and innovations, particularly in areas like gene editing and CRISPR therapies, as evidenced by the $70M raised by the Chinese startup YolTech.